Market Place
Sourcing Support
CDMO Nucleus RadioPharma reveals plan to triple capacity
21 Oct 2024 //
FIERCE PHARMA
Nucleus RadioPharma Expands Capacity For Radiopharmaceuticals
21 Oct 2024 //
BUSINESSWIRE
AstraZeneca Invests in Nucleus RadioPharma
05 Jun 2024 //
BIOSPACE
Nucleus RadioPharma: Series A Extension With AstraZeneca Investment
05 Jun 2024 //
BUSINESSWIRE
ARTBIO, Nucleus RadioPharma Collaborating On Radioisotope Products
07 May 2024 //
BUSINESSWIRE
Nucleus RadioPharma unveils manufacturing pact with ARTBIO
07 May 2024 //
FIERCE PHARMA
Nucleus RadioPharma Announces Appointment of Chris to Board of Directors
27 Mar 2024 //
BUSINESSWIRE
Nucleus RadioPharma: Building CDMO Sites to Ride the Radioligand Therapy Wave
28 Nov 2023 //
GENENG NEWS
SHINE and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatments
16 Nov 2023 //
BUSINESSWIRE
Nucleus RadioPharma Secures $56 Million Series A Funding
17 Oct 2023 //
BUSINESSWIRE
Mayo Clinic-backed Nucleus Radio raises $56M in Series A to boost CDMO services
17 Oct 2023 //
ENDPTS
Northstar Medical Radioisotopes, Nucleus Radiopharma Ink Supply Pact
27 Jun 2023 //
CONTRACT PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.